CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2

Neuropharmacology

Volumn 54, Issue 1, 2008, Pages 51-57

  Németh, Beáta ^a   Ledent, Catherine ^b   Freund, Tamás F ^a   Hájos, Norbert ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Brain slices; Cannabinoids; Glutamate; Hippocampus; Pyramidal cell; Transmitter release

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; GLUTAMIC ACID; OMEGA CONOTOXIN; BENZOXAZINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG INTERACTION; ELECTROSTIMULATION; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; NERVE CELL; NERVE CELL INHIBITION; NEWBORN; PATCH CLAMP; RADIATION RESPONSE;

ANIMALS; ANIMALS, NEWBORN; BENZOXAZINES; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; MORPHOLINES; NAPHTHALENES; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1;

EID: 37349034550     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.07.003     Document Type: Article

References (39)

1. Al-Hayani A., and Davies S.N. Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated. British Journal of Pharmacology 131 (2000) 663-665
2. Azad S.C., Eder M., Marsicano G., Lutz B., Zieglgansberger W., and Rammes G. Activation Of The Cannabinoid Receptor Type 1 Decreases Glutamatergic And Gabaergic Synaptic Transmission In The Lateral Amygdala Of The Mouse. Learning & Memory vol. 10 (2003), Cold Spring Harbor, NY pp. 116-128
3. Chemin J., Monteil A., Perez-Reyes E., Nargeot J., and Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO Journal 20 (2001) 7033-7040
4. Diana M.A., and Marty A. Characterization of depolarization-induced suppression of inhibition using paired interneuron-Purkinje cell recordings. Journal of Neuroscience 23 (2003) 5906-5918
5. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., Zieglgansberger W., Lutz B., and Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. Journal of Neuroscience 26 (2006) 5794-5799
6. Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A.L., and Mitchell R.L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molecular Pharmacology 48 (1995) 443-450
7. Fisyunov A., Tsintsadze V., Min R., Burnashev N., and Lozovaya N. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. Journal of Neurophysiology 96 (2006) 1267-1277
8. Freund T.F., Katona I., and Piomelli D. The role of endogenous cannabinoids in synaptic signaling. Physiological Reviews 83 (2003) 1017-1066
9. Gerdeman G., and Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. Journal of Neurophysiology 85 (2001) 468-471
10. Hájos N., and Freund T.F. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43 (2002) 503-510
11. Hájos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., and Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. European Journal of Neuroscience 12 (2000) 3239-3249
12. Hájos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
13. Hájos, N., Mann, E.O., Freund, T.F., Paulsen, O., 2005. Oxygen content of extracellular solution determines the stability of network oscillations in submerged hippocampal slices. 35th Society for Neuroscience Meeting, 275.18.
14. Haller J., Mátyás F., Soproni K., Varga B., Barsy B., Németh B., Mikics E., Freund T.F., and Hájos N. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic/glutamatergic synaptic transmission. European Journal of Neuroscience 25 (2007) 2445-2456
15. Hoffman A.F., and Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. Journal of Neuroscience 20 (2000) 2470-2479
16. Hoffman A.F., Riegel A.C., and Lupica C.R. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. European Journal of Neuroscience 18 (2003) 524-534
17. Hoffman A.F., Macgill A.M., Smith D., Oz M., and Lupica C.R. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. European Journal of Neuroscience 22 (2005) 2387-2391
18. Huang C.C., Lo S.W., and Hsu K.S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. Journal of Physiology 532 (2001) 731-748
19. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. Journal of Neuroscience 19 (1999) 4544-4558
20. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., and Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. Journal of Neuroscience 26 (2006) 5628-5637
21. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., and Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. Journal of Neuroscience 26 (2006) 2991-3001
22. Kofalvi A., Vizi E.S., Ledent C., and Sperlagh B. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. European Journal of Neuroscience 18 (2003) 1973-1978
23. Kofalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., and Sperlágh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. Journal of Neuroscience 25 (2005) 2874-2884
24. 2+ levels and transmitter release in the hippocampus. British Journal of Pharmacology 151 (2007) 551-563
25. Levenes C., Daniel H., Soubrie P., and Crepel F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. Journal of Physiology 510 (1998) 867-879
26. Matyas F., Yanovsky Y., Mackie K., Kelsch W., Misgeld U., and Freund T.F. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137 (2006) 337-361
27. Misner D.L., and Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. Journal of Neuroscience 19 (1999) 6795-6805
28. Nyiri G., Cserep C., Szabadits E., Mackie K., and Freund T.F. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136 (2005) 811-822
29. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., and Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. Journal of Neuroscience 22 (2002) 3864-3872
30. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., and Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 46 (2004) 115-125
31. Robbe D., Alonso G., Duchamp F., Bockaert J., and Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. Journal of Neuroscience 21 (2001) 109-116
32. Rouach N., and Nicoll R.A. Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. European Journal of Neuroscience 18 (2003) 1017-1020
33. Shen M., and Thayer S.A. The cannabinoid agonist Win 55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Research 783 (1998) 77-84
34. Shen M., Piser T.M., Seybold V.S., and Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. Journal of Neuroscience 16 (1996) 4322-4334
35. Straiker A., and Mackie K. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. Journal of Physiology 569 (2005) 501-517
36. Takahashi K.A., and Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139 (2006) 795-802
37. Takahashi K.A., and Linden D.J. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. Journal of Neurophysiology 83 (2000) 1167-1180
38. Varma N., Carlson G.C., Ledent C., and Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. Journal of Neuroscience 4 (2001) 4
39. Wilson R.I., Kunos G., and Nicoll R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31 (2001) 453-462